Network Approaches to Uncover Pathogenesis and Therapeutic Targets of Inflammatory Bowel Diseases [Published online in advanced , by J-STAGE]

[Advanced Published online The Keio Journal of Medicine, by J-STAGE]
<Title:> Network Approaches to Uncover Pathogenesis and Therapeutic Targets of Inflammatory Bowel Diseases
<Author(s):> Yohei Mikami , Takanori Kanai
<Corresponding author E-Mill:> yoheimikami(at)keio.jp
<Abstract:> Inflammatory bowel diseases (IBD) are currently recognized to involve chronic intestinal inflammation in genetically susceptible individuals. Patients with IBD mainly develop gastrointestinal inflammation, but it is sometimes accompanied by extraintestinal manifestations such as arthritis, erythema nodosum, episcleritis, pyoderma gangrenosum, uveitis, and primary sclerosing cholangitis. These clinical aspects imply the importance of interorgan networks in IBD. In the gastrointestinal tract, immune cells are influenced by multiple local environmental factors including microbiota, dietary environment, and intercellular networks, which further alter molecular networks in immune cells. Therefore, deciphering networks at interorgan, intercellular, and intracellular levels should help to obtain a comprehensive understanding of IBD. This review focuses on the intestinal immune system, which governs the physiological and pathological functions of the digestive system in harmony with the other organs.
<Keywords:> inflammatory bowel diseases, mucosal immunology, molecular targeted therapy, JAK STAT, neuroimmune interaction
<URL:> https://www.jstage.jst.go.jp/article/kjm/advpub/0/advpub_2022-0015-IR/_html

  • このエントリーをはてなブックマークに追加